Our preprint is now published: In collab. w/ Ruma Banerjee we show how the B12 chaperone MMADHC spends its life in two cellular 'zip codes' dictated by the mitochondrial PMF (similar to PINK1). Co-led by @Sneha_Rath_, Zhu Li. https://t.co/5gv3sjinA4
New today: We’ve published a webinar focused on Vascular Anomalies education, intended to support broader understanding of the disease area, existing therapeutic options & ongoing clinical development of zovegalisib, our mutant-selective PI3Kα inhibitor. https://t.co/TEfOxgwKai
Why do some genetic mutations devastate specific tissues while sparing others?
We explore this question in GGC repeat disorders, revealing a mechanism linking protein aggregation to tRNA splicing failure in the brain.
🧵 on our new paper in Science:
🔗 https://t.co/a9rB53kRoS
Congratulations to HHMI Investigator Vamsi Mootha (@VamsiMootha) of @HarvardMed and Navdeep Chandel of @NUFeinbergMed on being named recipients of the 2023 Lurie Prize in Biomedical Sciences by @FNIH_Org! https://t.co/YR0ekZoKrO
#MarathonMonday is coming quickly, and we are ready to cheer for Relayers who are running #Boston127! Here, we spotlight Megan Bonney, Aaron Dy and Emily Ullmann who are each experienced marathoners. This will be marathon #9 for Megan, #10 for Aaron and #11 for Emily. Best of luck to all our Relay Tx runners!
@lydfinley@MSKCancerCenter My undergrad thesis was on AMPK, and a few weeks before my defense this paper came out from @DrRGJonesLab. Provided a completely different way of thinking about AMPK for me. Also, p53 being regulated by metabolism??? That's not what the textbooks said!
https://t.co/yiLFU4kkRZ
Today we report in @nchembio the discovery and molecular basis of the first reported subtype-selective cyclophilin inhibitors. This work was a collaboration with the labs of Markus Seeliger and @VamsiMootha.
https://t.co/zM9zYUbDUL
1/9
@BrianNosek@OSFramework Academia is incentivized, from hiring to tenure to awards, to produce high impact papers in top Journals that demand the spectacular. Lack of reproducibly is rarely quantified or penalized. Pharma is rewarded for consistently reproducible data that enables an IND. Two solitudes